Study Explores Impact of FDA Approval of Aducanumab on Trial Participation

Individuals who were independently aware of the FDA decision demonstrated reduced willingness to participate

Source: The Doctors Lounge - Psychiatry - December 7, 2022 Category: Psychiatry Tags: Neurology, Pharmacy, Psychiatry, Journal, Source Type: news